Enalapril and losartan augment endogenous nitric oxide release in Takayasu's arteritis - A case report

Angiology

Volumn 51, Issue 1, 2000, Pages 69-75

  Marsen, Tobias A ^a   Sukau, Gudrun ^a   Pollok, Manfred ^a   Baldamus, Conrad A ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENALAPRIL; LOSARTAN; NITRIC OXIDE;

ADULT; AORTA ARCH SYNDROME; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; RENOVASCULAR HYPERTENSION;

EID: 0033957220     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970005100111     Document Type: Article

References (34)

1. Schrire V, Asherson RA: Arteritis of the aorta and its major branches. Q J Med 132: 439-462, 1964.
2. Sharma BK, Sagar S, Singh AP, et al: Takayasu's arteritis in India. Heart Vessels 7 (suppl):37-43, 1992.
3. Ooi BS, Chen BTM, Yu SF, et al: Primary arteritis of the aorta as a cause of renovascular hypertension in Singapore. Aust NZ J Med 1:132-136, 1971.
4. Koide K: Takayasu arteritis in Japan. Heart Vessels 7 (suppl):48-54, 1992.
5. Deyu Z, Dijun F, Lisheng L: Takayasu arteritis in China: A report of 530 cases. Heart Vessels 7 (suppl):32-36, 1992.
6. Piyachon C, Suwanwela N: Takayasu arteritis in Thailand. Heart Vessels 7(suppl): 60-67, 1992.
7. Park YB, Hong SK, Choi KJ, et al: Takayasu arteritis in Korea: Clinical and angiographic features. Heart Vessels 7(suppl):55-59, 1992.
8. Hall S, Barr MD, Lie JT, et al: Takayasu arteritis: A study of 32 North American patients. Medicine 64:89-99, 1985.
9. Ishikawa K: Natural history and classification of occlusive thromboaortopathy (Takayasu's disease). Circulation 57:27-35, 1978.
10. Hata A, Noda M, Moriwaki R, et al: Angiographic findings of Takayasu arteritis: New classification. Int J Cardiol 54:S155-S163, 1996.
11. Ishikawa K: Diagnostic approach and proposed criteria for the clinical diagnosis of Takayasu's arteriopathy. J Am Coll Cardiol 12:964-972, 1988.
12. Sharma BK, Iliskovic NS, Singal PK: Takayasu arteritis may be underdiagnosed in North America. Can J Cardiol 11:311-316, 1995.
13. Arend WP, Michel BA, Bloch DA, et al: The American College of Rheumatology 1990 criteria for the classification of Takayasu's arteritis. Arthritis Rheum 33:1129-1134, 1990.
14. Lupi Herrera E, Torres GS, Marcushamer J, et al: Takayasu arteritis: Clinical study of 107 cases. Am Heart J 93:94-103, 1977.
15. Yamato M, Lecky JW, Hiramatsu K, et al: Takayasu arteritis: Radiographic and angiographic findings in 59 patients. Radiology 161:329-334, 1986.
16. Subramanyan R, Joy J, Balakrishnan KG: Natural history of aortoarteritis (Takayasu's disease). Circulation 80:429-437, 1989.
17. Hoffman GS, Leavitt RY, Kerr GS, et al: Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum 37:578-582, 1994.
18. Shelhamer JH, Volkman DJ, Parrillo JE, et al: Takayasu's arteritis and its therapy. Ann Intern Med 103:121-126, 1985.
19. Numano F, Maruyama Y, Koyama T, et al: Antiaggregatory aspirin dosage at the affected vessel wall. Angiology 37:695-701, 1986.
20. Giordano JM, Leavitt RY, Hoffman G, et al: Experience with surgical treatment of Takayasu's disease. Surgery 109:252-258, 1991.
21. Kumar S, Mandalam KR, Rao VR, et al: Percutaneous transluminal angioplasty in non-specific aortoarteritis (Takayasu's disease): Experience of 16 cases. Cardiovasc Intervent Radiol 12:321-325, 1989.
22. Lüscher TF: Imbalance of endothelium-derived relaxing and contracting factors. A new concept in hypertension? Am J Hypertens 3:317-330, 1990.
23. Ito H, Hirata Y, Hiroe M, et al: Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res 69:209-215, 1991.
24. Garg UC, Hassid A: Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83:1774-1777, 1989.
25. Arnal J-F, Yamin J, Dockery S, et al: Regulation of endothelial nitric oxide synthase mRNA, protein, and activity during cell growth. Am J Physiol 267:C1381-1388, 1994.
26. Moncada S, Palmer RM, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-143, 1991.
27. Akazawa H, Ikeda U, Kuroda T, et al: Plasma endothelin-1 levels in Takayasu's arteritis. Cardiology 87:303-305, 1996.
28. Uyama O, Nagatsuka K, Nakamura M, et al: Plasma concentrations of 6-keto-prostaglandin F1 alpha in patients with hypertension, cerebrovascular disease or Takayasu's arteritis. Thromb Res 25:71-79, 1982.
29. Momose N, Kukuo K, Morimoto S, et al: Captopril inhibits endothelin-1 secretion from endothelial cells through bradykinin. Hypertension 21:921-924, 1993.
30. Bakris GL, Bhandaru S, Akerstrom V, et al: ACE inhibitor-mediated attenuation of mesangial cell growth. A role for endothelin. Am J Hypertens 7:583-590, 1994.
31. Auch-Schwelk W, Duske E, Claus M, et al: Endothelium-mediated vasodilation during ACE inhibition. Eur Heart J 16(suppl C):59-65, 1995.
32. Warren JB, Loi RK: Captopril increases skin microvascular blood flow secondary to bradykinin, nitric oxide, and prostaglandins. FASEB J 9:411-418, 1995.
33. Kahler J, Baldus S, Varendorff TV, et al: Captopril reduces endothelin-1 release from human umbilical vein endothelial cells by reduction of angiotensin II synthesis. J Am Coll Cardiol 27(suppl A):104A, 1996 (abstract).
34. 2 analogue in aortic rings from spontaneously hypertensive rats: Role of nitric oxide. J Hypertens 15:1677-1684, 1997.